Celera Taps Non-Profit Firm to Develop an Axys Candidate

Feb 14, 2002

NEW YORK, Feb. 14 - Celera Genomics on Thursday said that the National Institutes of Health and the Institute for OneWorld Health will co-develop a potential drug candidate it gained through its acquisition of Axys Pharmaceuticals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Main menu